1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. DBV TECHNOLOGIES - ADR

DBV Technologies - ADR

XNAS: DBVT

Download real time

6.20 2.29 (58.57%)

25.48% Fall from 52W High

21.7M XNAS Volume

High volume+gain today

XNAS 28 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
23S
3W
0O
2T
127.2

Market Cap

Below industry Median
-1.1

PE TTM

Negative PE TTM
0

PEG TTM

-

Price to Book

-0.5

Beta 1Year

Very Low volatility
Board Meeting
The latest board meeting for DBV Technologies - ADR took place on 28 Mar 2025, for the purpose of DBV Technologies SA Fourth Quarter Earnings Result for 2024 See details


Insider Trading disclosures for DBV Technologies - ADR

The latest disclosure was made by Pharis Mohideen in DBV Technologies - ADR where a trade of 600 Ordinary Shares done at an average price of $0.9 was reported to US exchanges on Jan. 30, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pharis Mohideen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.85 per share. 30 Jan 2025 600 110,510 (0%) 0% 0.9 510 Ordinary Shares
Pharis Mohideen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.57 per share. 22 Nov 2024 565 111,110 (0%) 0% 0.6 322 Ordinary Shares
Mohideen Pharis Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.53 per share. 22 Nov 2024 342 111,675 (0%) 0% 0.5 181 Ordinary Shares
Pharis Mohideen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 35,000 114,367 (0%) 0% 0 Ordinary Shares
Pharis Mohideen Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 215,000 215,000 - - Employee Stock Option (right to buy)
Pharis Mohideen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.54 per share. 21 Nov 2024 2,350 112,017 (0%) 0% 0.5 1,269 Ordinary Shares
Virginie Boucinha Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 19,000 38,000 (0%) 0% 0 Ordinary Shares
Virginie Boucinha Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 113,000 113,000 - - Employee Stock Option (right to buy)
Pharis Mohideen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.98 per share. 29 Jul 2024 1,785 79,367 (0%) 0% 1.0 1,749 Ordinary Shares
Pharis Mohideen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.38 per share. 22 May 2024 382 81,812 (0%) 0% 1.4 527 Ordinary Shares
Pharis Mohideen Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.36 per share. 22 May 2024 660 81,152 (0%) 0% 1.4 898 Ordinary Shares
Ndu Adora Director Purchase of securities on an exchange or from another person at price $ 0.89 per share. 06 Feb 2024 1,825 1,825 (0%) 0% 0.9 1,624 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters